While 2022 was a challenging year for life sciences companies to raise money from venture capital firms, Exton’s Castle Creek Biosciences was one of…

Exton-based Castle Creek Biosciences, a cell and gene therapy company, secured a nine-figure investment through financiers in an oversubscribed and upsized preferred stock…

Weeks after canceling its IPO plans, Exton-based Castle Creek Biosciences has acquired Novavita Thera, a Minnesota-based preclinical gene therapy company that focuses on…

Exton-based Castle Creek Biosciences has received a $1.8 million grant from the Food and Drug Administration to support late-stage clinical testing of…

As the pandemic-related business slumps abate, three life sciences companies made long-term commitments to the region. They’ve each signed leases for headquarters…